Utilities used to calculate QALYs were also obtained from the literature. Incremental analysis was conducted to assess cost-effectiveness in the base case analysis by comparing the incremental ...

We appreciate the responses to our Article,1 which suggest that the health cost of paying for new pharmaceuticals in the National Health Service (NHS), estimated at £1·25 million quality-adjusted life ...

Trimodal therapy improves quality of life compared with radical cystectomy in patients with muscle-invasive bladder cancer but is not cost-effective.

Objective To estimate the willingness to pay (WTP) per quality-adjusted life year (QALY) value for life-saving treatments and to determine factors affecting the WTP per QALY value. Design A ...

Real-World Evidence (RWE) can provide decision-makers in the healthcare sector with insights into the functioning of health technologies outside of clinical trial settings. In this report, we focus on ...

Current methods for constructing quality adjusted life year (QALY) measurements may be deficient for cancer patients in three respects: descriptions of health state, valuation of health state, and the ...

Figure 2. Estimated reductions in total CVD events and diabetes cases, gains in quality-adjusted life-years (QALYs), formal health care savings, and net savings from a health care perspective and a ...